查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物醫學冰箱和冰櫃市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190080

生物醫學冰箱和冰櫃市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Biomedical Refrigerator and Freezer Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，生物醫學冰箱和冰櫃市場預計將以 4.2% 的複合年增長率增長。

COVID-19 大流行擾亂了企業的研發活動。 它還影響了世界各地的治療方案以及藥物和醫療設備供應鏈，進一步影響了所研究的市場。 根據國家醫學圖書館 2021 年 1 月發表的一篇論文，隨著疫苗（包括破傷風疫苗）總劑量的下降，疫苗接種覆蓋率會下降，導致兒童無法接種疫苗。 同一消息來源說，大流行在三個不同層面上影響了疫苗接種。 對常規免疫接種的影響（包括免疫接種覆蓋率、兒科門診就診次數）、對大規模或補充免疫接種活動的影響、影響免疫接種覆蓋率的因素。 因此，整個市場都受到了 COVID-19 大流行的影響。 然而，由於大流行後的疫苗接種計劃，市場有望復蘇。

生物醫學冰箱和冰櫃是主要用於存儲生物樣本（例如血液、DNA 樣本和疫苗）的存儲容器。 預計推動生物醫學冰箱和冰櫃市場增長的主要因素是疾病負擔的增加、器官移植需求的增加以及產品技術的發展。 疾病負擔的增加和風險因素的增加將是預測期內推動研究領域增長的關鍵因素。 例如，根據國際糖尿病聯合會 (IDF) 2021 年 12 月的一份報告，2021 年約有 5.37 億 20 至 79 歲的成年人患有糖尿病，其中超過 90% 的人患有 2 型糖尿病，據信患有糖尿病。 糖尿病胰島素製劑需要持續給藥，因此需要長期調節，預計糖尿病患者的增加將增加對活體冷凍機的需求。 2021 年 10 月發布的法國人乳頭瘤病毒 (HPV) 和相關疾病報告表明，HPV16 和 18 在成年女性中流行。 4.7%的女性細胞學正常，26.3%患有低度宮頸疾病，60.6%患有高度宮頸疾病，75.6%患有宮頸癌。 HPV 是女性宮頸癌的常見原因。 因此，需要對該疾病進行早期診斷，這將在研究期間推動傳染病診斷市場。 因此，這種疾病患病率的增加也將推動市場增長。

然而，生物醫學冰箱和冰櫃價格昂貴，預計會阻礙市場增長。

主要市場趨勢

預計在預測期內市場細分將佔據很大份額

增加臨床試驗和產品發布等因素是市場增長的主要驅動力。 根據 clinicaltrials.gov 的數據，截至 2022 年，大約有 15,316 項涉及生物製藥的臨床試驗在美國註冊。 此外，藥物評估與研究中心 (CDER) 和食品藥品監督管理局 (FDA) 已於 2021 年在全球範圍內批准了 50 種藥物。 在實驗室中使用生物醫學冷凍機將藥物保持在理想溫度是最大限度提高藥物活力的重要領域之一。 因此，該國正在研究的藥物開發和臨床試驗的數量正在增加，這有望推動市場的增長。

此外，由於為治療該疾病開展了廣泛的研究活動，COVID-19 大流行一直是推動該領域增長的主要因素之一。 此外，產品發布也是推動市場增長的因素之一。 例如，2021 年 2 月，美國辛辛那提兒童醫院醫學中心與唐氏綜合徵（DSA）合作推出了研究生物庫。 它將作為唐氏綜合症患者及其親屬捐贈的生物樣本的中央儲存庫。 同樣，2022年1月，海爾生物醫療將致力於在製造和產品設計上不斷創新，為終端用戶提供功能、製冷效率和性能更佳的冰櫃。 我們還推出了新產品。 例如，2021年6月，海爾生物醫療推出了海爾生物醫療微型超低溫冰箱，適用於生物樣本庫、疫苗接種儲運等用戶。

因此，由於上述因素，該細分市場將在預測期內增長。

北美將佔據很大的市場份額，預計在預測期內也會如此

隨著疫苗產量的增加，預計北美將在全球生物醫學冰箱和冰櫃市場佔據很大的市場份額，這可能會增加對藥物儲存的需求。 根據 ClinicalTrial.gov 的數據，截至 2021 年 4 月，加拿大製藥公司和研究機構擁有強大的研發渠道。 該管道包括 5,659 項處於不同評估階段的新研究。 1,397 個 (24%) 正在進行 FDA 或 EMA 批准的 3 期臨床試驗，代表了廣泛的治療領域。 因此，越來越多的疫苗需要生物醫學冰箱來儲存。 人們將生物樣本庫用於與本國研究相關的各種用途。 例如，2021 年 4 月，從加拿大各地收集了超過 150,000 個樣本的 CanPath 開始對安大略健康研究 (OHS) 的 41,000 多名參與者進行基因組測序。 這是利用安大略省癌症研究所 (OICR) 加拿大數據集成中心的基因組技術平台進行的。 這些努力提供了適合支持許多廣泛的健康研究應用的研究，科學家們有興趣在這些應用中識別遺傳因素。 這些因素可能與疾病發展和健康老齡化有關，並可能增強我們對基因組如何與疾病發展相關的環境相互作用的理解。 此類應用和上述因素將需要使用生物銀行，預計這將在預測期內提高市場增長率。

競爭格局

生物醫學冰箱和冰櫃市場是分散的，由幾家大型企業組成。 目前，一些重要的參與者在市場份額方面佔據著市場主導地位。 目前主導市場的公司包括 Thermofisher Scientific Inc.、Terumo Corporation、Arctiko、Foilabo SAS、LabRepCo、Philips Kirsch GmbH、PHC Corporations、Haier Biomedical 和 Helmer Scientific Inc.。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 慢性病負擔加重
    • 對器官移植和生物製藥的需求不斷增長
  • 市場製約因素
    • 成本高
  • 波特的五力分析
    • 供應商的議價能力
    • 買方/消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品類型
    • 等離子冰箱
    • 血庫冰箱
    • 實驗室冰箱
    • 實驗室冰箱
    • 其他
  • 最終用戶
    • 醫院和診所
    • 生物樣本庫
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Aegis Scientific Inc.
    • Angelantoni Life Science
    • Arctiko
    • Eppendorf AG
    • Froilabo SAS
    • Haier Biomedical
    • Helmer Scientific Inc.
    • LabRepCo
    • PHC Corporations
    • Philips Kirsch GmbH
    • Terumo Corporation
    • Thermofisher Scientific Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 68193

The biomedical refrigerator and freezer market is expected to register a CAGR of 4.2% over the forecast period.

The COVID-19 pandemic disrupted the research and development activities of companies. Also, it impacted the treatment procedures and supply chain of pharmaceuticals and medical devices worldwide, further impacting the studied market. In January 2021, a paper published in the National Library of Medicine stated that there was a reduction in the total vaccination coverage along with a decline in the total number of vaccines administered (including tetanus vaccines), which led to children missing out on their vaccine doses. ​The same source stated the pandemic had affected immunization on three different levels. Impact on routine immunization (including immunization coverage; and pediatric clinic visits); impact on mass immunizations or supplementary immunization activities; and factors affecting immunization coverage.​ Hence, the overall market has been adversely affected by the COVID-19 pandemic. However, the market is expected to recover in the post-pandemic era due to vaccination programs.

Biomedical refrigerators and freezers are storage containers mainly used to store biological samples such as blood, DNA samples, vaccines, etc. Major factors expected to drive the growth of the biomedical refrigerator and freezer market are the growing disease burden, increasing organ transplantation demand, and the development of technology into products. The rising burden and increased risk factors of diseases will be significant factors driving the growth of the studied segment over the forecast period. For instance, according to the December 2021 report of the International Diabetes Federation (IDF), about 537 million adults of age 20-79 years were living with diabetes in 2021, and more than 90% of this population have Type 2 diabetes. Since the diabetes insulin drug requires to be contained for long periods as the patient requires constant dosage, the increase in diabetes is likely to increase the demand for biomedical freezers. The report "Human Papillomavirus (HPV) and Related Diseases Report France" published in October 2021, suggested HPV 16 and 18 prevalence among adult women. Women with normal cytology are 4.7%, with low-grade cervical lesions is 26.3%, with high-grade cervical lesions is 60.6% and with cervical cancer is 75.6%. HPV is the common cause of cervical cancer among women. Therefore there is a need for early diagnosis of the disease, which will boost the infectious disease diagnostic market during the study period. Thus, the increasing prevalence of the disease will also increase the market growth.

However, biomedical refrigerators and freezers are expensive, which is expected to hamper its market growth.

Key Market Trends

Laboratory Refrigerators Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Factors such as increasing clinical trials and product launches are critical factors in market growth. As per clinicaltrials.gov, around 15,316 clinical trials are presently registered in the US involving biopharmaceuticals in 2022. In addition, the Center for Drug Evaluation and Research (CDER) and Food and Drug Administration (FDA) approved 50 drugs worldwide in 2021. The use of biomedical freezers in the laboratory for maintaining pharmaceuticals at the ideal temperature is one of the essential areas to preserve the viability of the drug at maximum. This increasing number of drug developments and clinical trials studied in the country is anticipated to drive market growth.

Moreover, the COVID-19 pandemic is one of the major factors that drove the segment's growth, as extensive research activities were carried out to treat this disease. Furthermore, product launches are another factor in market growth. For instance, in February 2021, the Cincinnati Children's Hospital Medical Center in the US collaborated with DownSyndrome Achieves (DSA) to launch a research biobank. It serves as a central repository for biospecimens donated by individuals with Down Syndrome and their immediate families.​ Similarly, in January 2022, the chest range of biomedical freezers was revised as part of Haier Biomedical's commitment to ongoing innovation in manufacturing and product design to give end users a freezer with better functionality, cooling efficiency, and performance. The company also launched new products. For instance, in June 2021, Haier Biomedical launched the Haier Biomedical mini ULT freezer, which is suitable for biobanks, vaccination storage, and transportation users.

Thus, the segment will witness growth over the forecast period due to the above factors.​

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

With the increasing vaccine production, North America is expected to hold a significant market share in the global biomedical refrigerator and freezer market, which might increase the demand for drug storage. As of April 2021, according to ClinicalTrial.gov, Canadian pharmaceutical companies and research institutions have robust R&D pipelines. The pipeline contained 5,659 new studies in various stages of evaluation. 1,397 (24%) were in phase III clinical trials, approved through the FDA or EMA, representing a wide range of therapeutic areas. Thus, an increasing number of vaccines require biomedical freezers to store. People use biobanks for various applications related to research studies in the country. For instance, in April 2021, CanPath, with a total specimen of over 150,000 participants from across Canada, started genome sequencing of more than 41,000 participants in the Ontario Health Study (OHS). It was carried out by the Canadian Data Integration Centre using its genome technology platform, located at the Ontario Institute for Cancer Research (OICR). Such initiatives provide suitable studies to support many broad health research applications where scientists are interested in identifying genetic factors. These factors might be associated with disease development, healthy aging, or enhancing our understanding of how the genome interacts with the environment in terms of disease development. Such applications and the abovementioned factors will require the utilization of biobanks to increase market growth during the forecast period.

Competitive Landscape

The biomedical refrigerator and freezer market is fragmented and consists of several major players. A few significant players currently dominate the market in terms of market share. Some companies currently dominating the market are Thermofisher Scientific Inc., Terumo Corporation, Arctiko, Froilabo SAS, LabRepCo, Philips Kirsch GmbH, PHC Corporations, Haier Biomedical, and Helmer Scientific Inc, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Increasing Demand for Organ Transplantation and Biopharmaceuticals
  • 4.3 Market Restraints
    • 4.3.1 High Cost
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Plasma Freezers
    • 5.1.2 Blood Bank Refrigerators
    • 5.1.3 Laboratory Refrigerators
    • 5.1.4 Laboratory Freezers
    • 5.1.5 Others
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Bio Banks
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aegis Scientific Inc.
    • 6.1.2 Angelantoni Life Science
    • 6.1.3 Arctiko
    • 6.1.4 Eppendorf AG
    • 6.1.5 Froilabo SAS
    • 6.1.6 Haier Biomedical
    • 6.1.7 Helmer Scientific Inc.
    • 6.1.8 LabRepCo
    • 6.1.9 PHC Corporations
    • 6.1.10 Philips Kirsch GmbH
    • 6.1.11 Terumo Corporation
    • 6.1.12 Thermofisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS